ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 729635 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 729635; 2) Community: the network communities that were significantly associated with the response to NSC 729635; 3) Molecule: the relationships between components within communities and NSC 729635; 4) MDR: the compounds that were significantly associated with the NSC 729635.

NSC Compound Enrichment Correlation
NSC 63984 Cordycepin 0.0135588245836371 0.12902876
NSC 683556 Camptothecin Derivative 0.0135588245836371 0.21094644
NSC 685828 7H-Purine, 6-chloro-7-[2-deoxy-3-O-(4-methylphenyl)- 4-(4-methylphenoxy)-.beta.-D-erythrofuranosyl]- 0.0135588245836371 0.20530502
NSC 687663 Null 0.0135588245836371 0.10510073
NSC 700363 Liposomal Annamycin 0.0135588245836371 0.16183627
NSC 725666 6-[(5-Morpholyl-3-aminoethyl)-1-propyl]-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline 0.0135588245836371 0.21953978
NSC 733891 arypurine derivatives 0.0135588245836371 -0.16903278
NSC 741940 Null 0.0135588245836371 0.35954
NSC 747825 3-(4-fluorophenyl)-8,9-dimethyl-2-oxo-2,5-dihydropyrano[3,2-c]chromen-5-yl acetate 0.0135588245836371 -0.031092451
NSC 311152 6H-Pyrido[4,3-b]carbazolium, 2-[2-(diethylamino)ethyl]-9-hydroxy-5,11-dimethyl-, acetate (salt) (9CI) 0.0141354818755239 0.17445898
Total:24  Current:5    [First] [Prev] [Next] [Last]